Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “First-line Chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06846346
What this trial is testing

Testing Ivonescimab in Combination With Chemotherapy in Advanced or Metastatic Gastric/Gastroesophageal Adenocarcinoma

Who this might be right for
Metastatic Esophageal AdenocarcinomaAdvanced Esophageal AdenocarcinomaMetastatic Gastric Adenocarcinoma+1 more
UNICANCER 88
Testing effectiveness (Phase 2)WithdrawnNCT02885727
What this trial is testing

Durvalumab Plus "Booster" RT for Metastatic Adenocarcinoma Pancreas Cancer Post Chemotherapy (GCC 1598)

Who this might be right for
Metastatic Pancreas Cancer
University of Maryland, Baltimore
Not applicableUnknownNCT01619241
What this trial is testing

Pilot Study for Evaluating the Role of F-18 FLT PET/CT in Therapeutic Decision Making in Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
The Catholic University of Korea 15
Testing effectiveness (Phase 2)Study completedNCT04646005
What this trial is testing

Cemiplimab and ISA101b Vaccine in Adult Participants With Recurrent/Metastatic Human Papillomavirus (HPV)16 Cervical Cancer Who Have Experienced Disease Progression After First Line Chemotherapy

Who this might be right for
Cervical Cancer
Regeneron Pharmaceuticals 113
Large-scale testing (Phase 3)Active Not RecruitingNCT05652894
What this trial is testing

HX008 Compared to Chemotherapy in the First-Line Treatment of Subjects With MSI-H/dMMR Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Taizhou Hanzhong biomedical co. LTD 190
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07808359
What this trial is testing

Amivantamab in Patients With Metastatic/Recurrent Penile Squamous Cell Carcinoma

Who this might be right for
Penile Squamous Cell CarcinomaMetastatic Penile Squamous Cell Carcinoma
Latin American Cooperative Oncology Group 58
Large-scale testing (Phase 3)Ended earlyNCT01840943
What this trial is testing

Compare CAELYX With Topotecan HCL in Patients With Recurrent Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based Chemotherapy

Who this might be right for
Epithelial Ovarian Cancer
Xian-Janssen Pharmaceutical Ltd. 32
Testing effectiveness (Phase 2)UnknownNCT00786110
What this trial is testing

Sorafenib Plus Paclitaxel in Adreno-Cortical-Cancer Patients

Who this might be right for
Adrenocortical Carcinoma
University of Turin, Italy 30
Testing effectiveness (Phase 2)Looking for participantsNCT05188859
What this trial is testing

First Line Sintilimab Combined With Anlotinib and Platinum Doublet Chemotherapy in Malignant Pleural Mesothelioma

Who this might be right for
Mesothelioma, MalignantMesothelioma, Malignant PleuralMesothelioma Malignant Advanced
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 29
Testing effectiveness (Phase 2)Ended earlyNCT02564380
What this trial is testing

Study of Pembrolizumab Maintenance Following First-Line Platinum Based Chemotherapy in Patients With Metastatic Squamous - Non-Small Cell Lung Cancer (sNSCLC)

Who this might be right for
Metastatic Squamous Non-small Cell Lung Cancer
AIO-Studien-gGmbH 41
Testing effectiveness (Phase 2)Study completedNCT05505825
What this trial is testing

AK104 in Combination With Chiauranib in Patients With Extensive Stage Small Cell Lung Cancer

Who this might be right for
SCLC,Extensive Stage
Akeso 36
Not applicableStudy completedNCT03156868
What this trial is testing

Analysis of Soluble Mediators,Cytokines and FACs as Prognostic Factors in Advanced Non-squamous Lung Carcinoma

Who this might be right for
Non-small Cell Lung Cancer
Spanish Lung Cancer Group 153
Not applicableStudy completedNCT04281576
What this trial is testing

Effect of Tumor Treating Fields (TTFields, 150 KHz) Concomitant with Chemotherapy As First Line Treatment of Unresectable Gastroesophageal Junction or Gastric Adenocarcinoma

Who this might be right for
Gastric CancerGastroEsophageal Cancer
NovoCure Ltd. 28
Not applicableStudy completedNCT05774990
What this trial is testing

Study Protocol: Study on Incidence and Risk Factors of Mold Infections in Children During Leukemia Treatment

Who this might be right for
Leukemia, Myeloid, AcuteAcute Lymphoblastic Leukemia
University of Southern Denmark 621
Testing effectiveness (Phase 2)UnknownNCT03751176
What this trial is testing

Second-line FOLFIRI + Panitumumab in Subjects With Wild Type RAS Metastatic Colorectal

Who this might be right for
Colorectal Cancer Metastatic
Grupo Espanol Multidisciplinario del Cancer Digestivo 31
Not applicableActive Not RecruitingNCT04794010
What this trial is testing

A Study in Participants With First-Line Nivolumab Plus Ipilimumb Therapy Combined With Two Cycles of Chemotherapy for Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Bristol-Myers Squibb 825
Early research (Phase 1)Ended earlyNCT01915524
What this trial is testing

Trial of RNActive®-Derived Cancer Vaccine and Local Radiation in in Stage IV Non Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small Cell Lung Carcinoma
CureVac 26
Not applicableStudy completedNCT01340443
What this trial is testing

An Observational Study of MabThera/Rituxan (Rituximab) Plus Chemotherapy As First-Line Treatment in Patients With Diffuse Large B-Cell Lymphoma or Follicular Lymphoma

Who this might be right for
Diffuse Large B-Cell Lymphoma
Hoffmann-La Roche 314
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07756190
What this trial is testing

Radscopal Radiotherapy Plus Immunotherapy for Chemotherapy-Ineligible Patients With Newly Diagnosed Metastatic Nasopharyngeal Cancer: A Single-Center, Open-Label, Phase II Study

Who this might be right for
Nasopharyngeal Carcinoma (NPC)Metastatic Nasopharyngeal Carcinoma
Sun Yat-sen University 28
Not applicableStudy completedNCT06149390
What this trial is testing

ASCT Versus Chemotherapy as First-Line Consolidation Therapy inT-Cell Lymphoma

Who this might be right for
T-cell Lymphoma Adults
Huazhong University of Science and Technology 347
Next Page